Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NNC 01940499

Drug Profile

NNC 01940499

Alternative Names: NN 9500; NN9499; NNC-0194-0499

Latest Information Update: 27 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novo Nordisk
  • Class Hepatoprotectants; Obesity therapies
  • Mechanism of Action Fibroblast growth factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Non-alcoholic steatohepatitis
  • Phase I Non-alcoholic fatty liver disease
  • No development reported Obesity

Most Recent Events

  • 09 Feb 2024 Novo Nordisk completes a phase I trial in Non-alcoholic steatohepatitis (Monotherapy, In volunteers) and Non-alcoholic steatohepatitis (Combination therapy, In volunteers) in Canada (SC) (NCT05766709)
  • 18 Dec 2023 Phase-I clinical trials in Non-alcoholic steatohepatitis (In volunteers) in Austria (SC) (NCT06188026)
  • 10 Nov 2023 Novo Nordisk completes a phase I trials in Non-alcoholic steatohepatitis (In adults, In the elderly) in Germany (SC) (NCT05727644) (EudraCT2022-001849-20)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top